2020 RESEARCH
- Archives -UMMS study shows home oxygen monitoring safe for premature infants, can shorten treatment
A new study led by Lawrence M. Rhein, MD, MPH, and Ted M. Kremer, MD, at UMass Medical School, and colleagues at nine clinical sites throughout the United States has found that parents of premature infants on home oxygen therapy can safely and effectively report babies’ oxygen levels in between clinic visits.
UMMS researchers forging new understanding of BRCA cancer gene function with NCI grant
A UMass Medical School research team has been awarded a National Cancer Institute grant to advance understanding of how hereditary breast and ovarian cancer genes work, and why tumors lacking these genes are sensitive to chemotherapy.
Silencing of an ALS gene safely delivered to patients in UMass Medical School study
UMass Medical School and Massachusetts General Hospital are the first to safely treat two research participants with a synthetic microRNA, delivered into the spinal fluid, designed to silence a human disease-causing gene. Details of the treatment appear in the New England Journal of Medicine.
UMass Medical School researchers visualize new states of ribosome translation with cryo-EM
The states through which ribosomes, the molecular machines responsible for reading genetic information, synthesize life-sustaining proteins have been revealed in unprecedented time-resolved detail by UMass Medical School structural biologists Andrei Korostelev, PhD, and Anna Loveland, PhD.
‘Guts and bugs:’ GSBS student talks GI immunity and inflammation in virtual seminar series
Sage Foley, PhD candidate in the Graduate School of Biomedical Sciences, presented her research at a weekly virtual event put on by Rutgers University, called “Guts & Bugs: A Virtual GI Seminar Series.”
LISTEN: How monoclonal antibodies can help fight infectious diseases, such as Lyme disease
In a new Voices of UMassMed podcast, Mark Klempner, MD, talks about promising new research into infectious diseases, including Lyme disease, at MassBiologics of UMass Medical School.
Gene therapy and CRISPR strategies for curing blindness
In a piece originally published on The Conversation, Hemant Khanna, PhD, comments on recent studies that use CRISPR to treat diseases that cause blindness and explains why the eye is an ideal organ for testing new therapeutic approaches.
Yasaman Gholamalipour awarded fellowship by Huntington’s Disease Society of America
UMass Medical School postdoctoral associate Yasaman Gholamalipour, PhD, was awarded the Huntington’s Disease Society of America Berman-Topper Family HD Career Development Fellowship for 2020.
Mobile addiction care service to offer outreach to high-risk populations
UMass Medical School is a partner in an innovative mobile addiction services contract funded by the Massachusetts Department of Public Health.
UMass research and development expenditures rise to record $684 million
Research expenditures at the University of Massachusetts increased by $33 million in one fiscal year to a record high of $684 million in fiscal year 2019. At UMass Medical School, research expenditures rose by 2.7 percent to $281.51 million.